Intellectual Property Watch was an independent newspaper that covered international IP policy from 2005-2019

Explore its archives with the menu or the link below.

Latest articles

WHO Member States Call For Transparency, Access To Innovation On Cancer Drug Pricing

WHO Member States Call For Transparency, Access To Innovation On Cancer Drug Pricing

David Branigan Jan 30, 2019 1 min read

A substantive discussion took place at the World Health Organization Executive Board meeting yesterday in response to a recently released WHO report on cancer drug pricing. Among the variety of…

WHO Holds Discussions On Roadmap For Improving Access To Medicines

WHO Holds Discussions On Roadmap For Improving Access To Medicines

Catherine Saez Jan 29, 2019 1 min read

Unaffordable prices, unavailable medicines, a rising need for accessible noncommunicable diseases treatments – these set the stage as the World Health Organization Executive Board started discussion today on one of…

DNDi, MMV Make 400 Compounds Available To Boost Pandemic Disease Research

William New Jan 29, 2019 1 min read

The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) today announced the launch of the “Pandemic Response Box”, which offers researchers open access to 400 compounds…

Measuring Outputs Seen As Key To WHO Transformation

Measuring Outputs Seen As Key To WHO Transformation

Catherine Saez Jan 29, 2019 1 min read

Measurable outputs are a key element of the World Health Organization transformation and its “triple billion” target. Last week, WHO Executive Board discussed the Impact Framework, a key measurement system.…

WHO Draft Resolution On Universal Health Coverage Shows Efforts At Consensus

WHO Draft Resolution On Universal Health Coverage Shows Efforts At Consensus

Catherine Saez Jan 28, 2019 1 min read

With half the world’s population still lacking access to essential health services, World Health Organization Executive Board members this week are working to agree on a resolution indicating ways through…

Latest articles

WHO Cancer Report Stirs Debate On Eve Of Board Meeting

WHO Cancer Report Stirs Debate On Eve Of Board Meeting

As the World Health Organization Executive Board gathers tomorrow for its annual January meeting, health industry and advocacy groups have seized on a WHO report to be presented to the Board that find…

Read More
Special Report: Guide To This Week’s WHO Board Meeting – Budget, Medicines Access, Antimicrobial Resistance, NCDs, More

Special Report: Guide To This Week’s WHO Board Meeting – Budget, Medicines Access, Antimicrobial Resistance, NCDs, More

The World Health Organization Executive Board this month will consider an 8 percent WHO budget increase for 2020-2021, discuss environment health risks, the high price of cancer drugs, and how to faci…

Read More
Sudden Vacancies At Some International Agencies, Industry Sees New Top Officials, Lawyers Engage In Firm-Hopping

Sudden Vacancies At Some International Agencies, Industry Sees New Top Officials, Lawyers Engage In Firm-Hopping

While the World Bank Group and the United Nations Environment Programme (UNEP) are looking for new leaders following the unexpected resignations of their heads, the International Telecommunication Uni…

Read More
Nearly 100 European Authors Demand ‘Proportionate’ Remuneration In EU Copyright Directive

Nearly 100 European Authors Demand ‘Proportionate’ Remuneration In EU Copyright Directive

With negotiations for the European Union Copyright Directive apparently approaching an end, a group of some 95 screenwriters and directors joined the intensive lobbying efforts with a letter today urg…

Read More
European Council Advances SPC Waiver For Generics; Negotiations Coming

European Council Advances SPC Waiver For Generics; Negotiations Coming

The European Union Council of member states has approved a mandate for negotiations with the EU Parliament concerning a draft regulation aimed at boosting EU-based generic and biosimilar manufacturing…

Read More
Supporting UHC And Better Explaining IP – The 2019 Pharma Industry Agenda

Supporting UHC And Better Explaining IP – The 2019 Pharma Industry Agenda

In 2019, IFPMA work will continue to focus on constructive engagement in supporting UHC and working with others to strengthen health care systems. The association will continue to engage with a range …

Read More
1 10 11 12 13 14 1,213